Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
CELZ

CELZ - Creative Medical Technology Holdings Stock Price, Fair Value and News

$2.210.00 (0.00%)
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

CELZ Price Action

Last 7 days

-17.2%

Last 30 days

-26.3%

Last 90 days

-32.8%

Trailing 12 Months

-9.8%

CELZ RSI Chart

CELZ Valuation

Market Cap

5.7M

Price/Earnings (Trailing)

-0.96

Price/Sales (Trailing)

708.47

EV/EBITDA

-0.05

Price/Free Cashflow

-0.97

CELZ Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

CELZ Fundamentals

CELZ Revenue

Revenue (TTM)

11.0K

Rev. Growth (Yr)

-100%

Rev. Growth (Qtr)

-100%

CELZ Earnings

Earnings (TTM)

-6.0M

Earnings Growth (Yr)

-18.82%

Earnings Growth (Qtr)

-0.21%

CELZ Profitability

Operating Margin

78.18%

EBT Margin

-54194.62%

Return on Equity

-106.61%

Return on Assets

-101.85%

Free Cashflow Yield

-102.9%

CELZ Investor Care

Shares Dilution (1Y)

47.59%

Diluted EPS (TTM)

-1.98

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20250000
20249.5K10.0K10.5K11.0K
2023161.5K251.4K302.6K9.0K
2022102.8K92.8K120.8K115.3K
20210132.4K114.5K105.3K
2020165.3K165.0K164.8K164.5K
2019165.6K222.4K227.5K165.5K
201834.7K64.6K94.5K124.4K
20170004.8K
201615.4K000
201517.6K17.8K18.0K19.8K
201419.0K18.6K18.6K18.7K
201319.9K20.2K19.7K19.4K
201219.3K19.7K20.3K19.2K
201115.1K16.1K17.0K18.0K
201000014.1K
Get all data in R, Python etc through our Historical Stock Data APIs

About Creative Medical Technology Holdings

CELZ
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
 CEO
 WEBSITEcreativemedicaltechnology.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES4

Creative Medical Technology Holdings Frequently Asked Questions

What is the ticker symbol for Creative Medical Technology Holdings? What does CELZ stand for in stocks?

CELZ is the stock ticker symbol of Creative Medical Technology Holdings. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Creative Medical Technology Holdings (CELZ)?

As of Wed Dec 03 2025, market cap of Creative Medical Technology Holdings is 5.7 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CELZ stock?

You can check CELZ's fair value in chart for subscribers.

Is Creative Medical Technology Holdings a good stock to buy?

The fair value guage provides a quick view whether CELZ is over valued or under valued. Whether Creative Medical Technology Holdings is cheap or expensive depends on the assumptions which impact Creative Medical Technology Holdings's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CELZ.

What is Creative Medical Technology Holdings's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, CELZ's PE ratio (Price to Earnings) is -0.96 and Price to Sales (PS) ratio is 708.47. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CELZ PE ratio will change depending on the future growth rate expectations of investors.